查看購物車
  • English
  • Japanese
封面
市場調查報告書
商品編碼
2018724

機器人內視鏡設備市場：依設備類型、技術、應用和最終用戶分類－2026-2032年全球市場預測

Robotic Endoscopy Devices Market by Device Type, Technology, Application, End User - Global Forecast 2026-2032
出版日期: | 出版商: 360iResearch | 英文 183 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

預計到 2025 年，機器人內視鏡設備市場價值將達到 37 億美元，到 2026 年將成長至 43.5 億美元，到 2032 年將達到 125.9 億美元，複合年成長率為 19.12%。

主要市場統計數據
基準年 2025 37億美元
預計年份：2026年 43.5億美元
預測年份 2032 125.9億美元
複合年成長率 (%) 19.12%

簡要概述了各專業領域內機器人內視鏡技術的進步、推動臨床應用的因素以及塑造其發展趨勢的策略挑戰。

機器人內視鏡領域融合了微創手術和數位外科輔助技術的創新成果。近年來，執行器小型化、影像解析度和感測器整合方面的進步，徹底改變了臨床醫生對多個器官系統進行複雜診斷和治療性介入的方式。因此，與傳統內視鏡平台相比，臨床團隊能夠獲得更高的操作便利性、更短的手術時間和更佳的人體工學體驗。

分析正在重新定義臨床工作流程和實施趨勢的整合技術創新、監管變化和經營模式。

由於技術、臨床和商業性因素的融合，機器人內視鏡領域正經歷著一場變革。微型化的致動器和改進的觸覺回饋使得在解剖結構受限的區域內能夠進行更精確的操作，而光學系統和人工智慧輔助視覺化技術的進步則增強了病變檢測和手術決策支援。這些技術要素並非孤立發揮作用，而是透過使更複雜的內視鏡手術介入成為可能，從而重塑了臨床路徑，使醫生能夠在管腔內而非透過開放性手術或腹腔鏡手術進行操作。

評估近期美國關稅變化如何重塑全球供應鏈、籌資策略以及機器人內視相關人員的採購決策。

近年來，源自美國的政策變革和貿易措施重新引發了人們對全球醫療設備供應鏈韌性和先進治療平台成本結構的關注。關稅調整對價值鏈上的多個環節都造成了壓力，從精密組件和成像模組到成品，都可能受到影響，並可能影響製造地的選擇、關鍵子系統的採購方式以及戰略夥伴關係中首選供應商的確定。

詳細的細分分析揭示了醫療設備類型、臨床應用、平台技術、終端用戶環境和銷售管道如何推動採用和差異化。

不同類型的醫療設備對於臨床團隊、採購部門和研發人員確定投資優先順序至關重要。診斷系統兼具切片檢查功能和影像平台，因其能夠在不造成顯著組織損傷的情況下提高早期檢測和病灶定性能力而備受重視。另一方面，治療器械則著重於介入治療功能，例如消融、止血和切除，其機器人架構能夠實現穩定、精確的能量傳輸和可控的組織操作。

區域趨勢：本節詳細介紹了不同的醫療保健系統、法規環境和採購模式如何影響機器人內視鏡技術創新的採用和推廣。

地理因素影響技術引進週期、監管互動和商業化路徑。在美洲，密集的大學醫院網路、大規模綜合醫療保健系統和私人門診機構為早期臨床檢驗和穩健的商業模式提供了沃土。該地區的報銷框架和醫療採購流程影響著那些能夠顯著提高手術效率並帶來可重複臨床結果的平台的優先順序。

從企業層面洞察產品差異化、臨床證據的取得、夥伴關係、決定競爭地位的營運措施。

機器人內視鏡領域的競爭動態體現了傳統醫療設備巨頭進軍機器人領域與敏捷的新興參與企業專注於顛覆性平台功能之間的平衡。主要企業的策略包括：透過研究人員主導和公司支持的研究來產生臨床證據；開發整合服務和培訓方案以降低應用門檻；以及與醫院和學術機構建立夥伴關係，以加速實際檢驗。

為開發人員、醫療保健提供者和銷售團隊提供切實可行的策略建議，以加速產品採用、降低供應風險並確保永續的臨床價值。

產業領導者應優先考慮將設備創新與切實可行的部署策略相結合的綜合方法。首先，他們必須投資於強力的臨床證據項目，以解決支付方和醫療服務提供者重視的真實世界終點，並確保將培訓途徑整合到商業部署中，從而降低推廣應用的障礙。其次，他們必須透過區域採購、關鍵零件的雙重採購安排以及與契約製造建立合作關係來增強供應鏈韌性，最大限度地降低貿易中斷和關稅相關成本壓力的風險。

清晰的調查方法，詳細說明了與關鍵相關人員的互動、觀察分析以及用於產生可操作見解的二手技術和監管審查。

本執行摘要所依據的綜合研究採用多方面方法，結合了與關鍵相關人員的溝通以及相關的技術和法規審查。關鍵資訊包括與臨床負責人、採購主管和設備工程師進行結構化訪談，以了解實際部署中遇到的障礙、培訓需求和組件採購流程。除這些訪談外，還開展了有針對性的實地考察和監考觀察，以深入了解工作流程影響和使用者體驗的細微差別。

摘要重點闡述了臨床潛力、實施的操作前提條件以及決定長期成功的策略要素。

機器人輔助內視鏡在微創醫學的廣泛發展中佔據著至關重要的地位，具有提高診斷準確性和減輕患者治療性介入負擔的實際潛力。驅動技術、先進成像技術和智慧軟體的整合，使其在支氣管鏡學、消化內科、耳鼻喉科和泌尿系統等領域得以應用，而多樣化的平台技術則滿足了廣泛的臨床和操作需求。

目錄

第1章：序言

第2章：調查方法

  • 調查設計
  • 研究框架
  • 市場規模預測
  • 數據三角測量
  • 調查結果
  • 調查的前提
  • 研究限制

第3章執行摘要

  • 首席主管觀點
  • 市場規模和成長趨勢
  • 2025年市佔率分析
  • FPNV定位矩陣，2025
  • 新的商機
  • 下一代經營模式
  • 產業藍圖

第4章 市場概覽

  • 產業生態系與價值鏈分析
  • 波特五力分析
  • PESTEL 分析
  • 市場展望
  • 上市策略

第5章 市場洞察

  • 消費者洞察與終端用戶觀點
  • 消費者體驗基準
  • 機會映射
  • 分銷通路分析
  • 價格趨勢分析
  • 監理合規和標準框架
  • ESG與永續性分析
  • 中斷和風險情景
  • 投資報酬率和成本效益分析

第6章：美國關稅的累積影響，2025年

第7章：人工智慧的累積影響，2025年

第8章：機器人內視鏡設備市場：依設備類型分類

  • 診斷
    • 切片檢查
    • 診斷影像
  • 治療
    • 消融術
    • 止血
    • 切除

第9章：機器人內視鏡設備市場：依技術分類

  • 膠囊內視鏡
  • 軟性機器人內視鏡
  • 剛性機器人內視鏡

第10章：機器人內視鏡設備市場：依應用領域分類

  • 支氣管
  • 消化系統
    • 下消化道
    • 上消化道
  • 耳鼻喉科
  • 泌尿系統

第11章：機器人內視鏡設備市場：依最終用戶分類

  • 門診手術中心
  • 診所
  • 醫院
  • 研究機構

第12章：機器人內視鏡設備市場：依地區分類

  • 北美洲和南美洲
    • 北美洲
    • 拉丁美洲
  • 歐洲、中東和非洲
    • 歐洲
    • 中東
    • 非洲
  • 亞太地區

第13章：機器人內視鏡設備市場：依組別分類

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

第14章：機器人內視鏡設備市場：依國家分類

  • 美國
  • 加拿大
  • 墨西哥
  • 巴西
  • 英國
  • 德國
  • 法國
  • 俄羅斯
  • 義大利
  • 西班牙
  • 中國
  • 印度
  • 日本
  • 澳洲
  • 韓國

第15章：美國機器人內視鏡設備市場

第16章：中國機器人內視鏡設備市場

第17章 競爭格局

  • 市場集中度分析，2025年
    • 濃度比（CR）
    • 赫芬達爾-赫希曼指數 (HHI)
  • 近期趨勢及影響分析，2025 年
  • 2025年產品系列分析
  • 基準分析，2025 年
  • Ambu A/S
  • Asensus Surgical, Inc.
  • avateramedical GmbH
  • Boston Scientific Corporation
  • Brainlab AG
  • CMR Surgical Ltd.
  • Cook Group Incorporated
  • EndoMaster Pte Ltd
  • Endotics
  • Globus Medical, Inc.
  • Intuitive Surgical, Inc.
  • KARL STORZ SE & Co. KG
  • Medtronic PLC
  • MicroPort Scientific Corporation
  • Olympus Corporation
  • Otsuka Holdings Co., Ltd.
  • Renishaw PLC
  • Ronovo Surgical
  • Stryker Corporation
  • Virtuoso Surgical, Inc.
Product Code: MRR-CA17E905E71D

The Robotic Endoscopy Devices Market was valued at USD 3.70 billion in 2025 and is projected to grow to USD 4.35 billion in 2026, with a CAGR of 19.12%, reaching USD 12.59 billion by 2032.

KEY MARKET STATISTICS
Base Year [2025] USD 3.70 billion
Estimated Year [2026] USD 4.35 billion
Forecast Year [2032] USD 12.59 billion
CAGR (%) 19.12%

Concise introduction outlining technological evolution, clinical adoption drivers, and strategic tensions shaping robotic endoscopy across specialties

The field of robotic endoscopy sits at the intersection of minimally invasive procedural innovation and digital surgical augmentation. Recent advances in actuator miniaturization, imaging fidelity, and sensor integration have reshaped how clinicians approach complex diagnostic and therapeutic interventions across multiple organ systems. As a result, clinical teams are increasingly able to perform procedures with enhanced dexterity, reduced procedure times, and improved ergonomics compared with legacy endoscopic platforms.

Alongside technical progress, an expanding portfolio of flexible and rigid platforms, plus swallowable capsule technologies, has broadened clinical applicability from bronchial and otolaryngological procedures to comprehensive gastrointestinal and urological workflows. This diversification is enabling device suppliers to pursue specialized applications while healthcare providers evaluate pathways to adopt robotics where clinical benefit and workflow efficiency align.

Transitions in regulatory expectations, reimbursement frameworks, and hospital procurement priorities are accelerating adoption choices. Consequently, stakeholders must balance clinical outcomes with capital deployment, training pathways, and service delivery models. The remainder of this executive summary synthesizes those dynamics and frames practical considerations for clinical leaders, device developers, and commercial strategists operating in the robotic endoscopy space.

Analysis of converging technological innovations, regulatory shifts, and commercial models that are redirecting clinical workflows and adoption dynamics

The robotic endoscopy landscape is undergoing transformative shifts driven by converging technological, clinical, and commercial forces. Miniaturized actuators and improved haptic feedback have enabled more precise manipulation in constrained anatomies, while advances in optical systems and AI-assisted visualization are enhancing lesion detection and intra-procedural decision support. These technology vectors are not acting in isolation; they are reshaping clinical pathways by enabling more complex interventions to be performed endolumenally rather than through open or laparoscopic approaches.

Commercial models are evolving in parallel. Device developers are experimenting with outcome-based procurement arrangements, service contracts, and bundled offerings that include training and lifecycle support. Hospitals and ambulatory providers are increasingly evaluating total cost of ownership rather than capital price alone, which places a premium on modular platforms that can support multiple use cases across procedural areas. Meanwhile, regulatory bodies are clarifying pathways for software updates and AI-enabled features, which has implications for product roadmaps and post-market surveillance obligations.

Operationally, integration into established clinical workflows remains a critical barrier and opportunity. Clinical champions are essential to accelerate adoption, but effective training curricula, proctoring models, and demonstrable workflow efficiencies are equally important. As the market matures, collaboration across device manufacturers, health systems, and academic centers will determine which innovations transition from proof-of-concept to standard of care.

Assessment of how recent United States tariff changes are reshaping global supply chains, sourcing strategies, and procurement decisions for robotic endoscopy stakeholders

Policy changes and trade measures originating from the United States in recent years have brought renewed attention to the resilience of global medical device supply chains and the cost structures of advanced procedural platforms. Tariff adjustments exert pressure across multiple nodes of the value chain, from precision components and imaging modules to finished assemblies, and they can influence decisions about where to manufacture, how to source critical subsystems, and which suppliers to prioritize for strategic partnerships.

In response, many manufacturers have accelerated supplier diversification and pursued nearshoring or regional manufacturing strategies to mitigate exposure to tariff volatility. These initiatives are often accompanied by redesign efforts aimed at substituting tariff-exposed components with alternatives that are readily sourced within target regions, and by renegotiated commercial terms with contract manufacturers and logistics providers. Healthcare providers and group purchasing organizations have also reacted by reassessing procurement frameworks to account for potential price variability and longer lead times for specialized instrumentation.

Regulatory compliance and import documentation practices have become more central to commercial planning, and firms are investing in customs expertise to minimize administrative friction. At the same time, alternative strategies such as increased vertical integration or dual-sourcing of critical components are being explored to preserve continuity of supply. Overall, the cumulative impact of tariff-related pressures has emphasized resilience, flexibility, and a willingness to reengineer supply chains to protect product availability and control unit costs under shifting trade conditions.

In-depth segmentation analysis clarifying how device type, clinical application, platform technology, end-user environment, and sales channel drive adoption and differentiation

Device type distinctions are central to how clinical teams, purchasing groups, and developers prioritize investments. Diagnostic systems, which encompass both biopsy-capable devices and imaging-focused platforms, are valued for their ability to enhance early detection and lesion characterization without extensive tissue disruption. Therapeutic devices, on the other hand, emphasize intervention capabilities such as ablation, hemostasis, and resection, where the robotic architecture can deliver stable, precise energy delivery and controlled tissue manipulation.

Application-driven segmentation determines clinical workflows and training requirements. Bronchial platforms face challenges related to airway access and sensor stabilization, while gastrointestinal applications require navigation across proximal and distal anatomy with distinct imaging and tool-delivery needs for upper and lower procedures. Otolaryngological and urological uses impose their own ergonomic and instrument-design constraints, reinforcing the need for differentiated platform features.

Technology choices-capsule endoscopes, flexible robotic endoscopes, and rigid robotic endoscopes-create trade-offs among patient comfort, controllability, and instrument payload. Capsule systems emphasize noninvasiveness and diagnostic convenience, flexible robotic platforms prioritize reach and navigation in tortuous anatomies, and rigid platforms deliver stability and force for certain therapeutic interventions. End-user settings influence purchasing rationale and support models; ambulatory surgical centers seek compact, turnaround-efficient systems, clinics optimize for outpatient diagnostics and referral pathways, hospitals focus on integrated suites that support multidisciplinary procedures, and research institutes prioritize modularity and access for iterative development. Sales channels further affect adoption speed and support intensity, with direct-sales approaches enabling tailored service agreements and distribution models offering broader geographic coverage and scalability.

Regional intelligence detailing how distinct healthcare systems, regulatory environments, and procurement models influence adoption and scaling of robotic endoscopy innovations

Geographic dynamics shape technology adoption cycles, regulatory engagement, and commercialization pathways. In the Americas, a dense network of academic medical centers, large integrated health systems, and private ambulatory facilities creates fertile ground for early clinical validation and high-touch commercial models. Reimbursement frameworks and institutional procurement processes in this region influence the prioritization of platforms that demonstrate clear procedural efficiency gains and reproducible clinical outcomes.

The Europe, Middle East & Africa region presents a heterogeneous landscape where regulatory harmonization, national procurement policies, and diverse healthcare delivery models affect product rollout strategies. In some countries, centralized purchasing and rigorous health-technology assessment pathways require robust evidence generation and local clinical partnerships, while in others faster adoption is enabled by less centralized procurement and capital investment from private providers.

Asia-Pacific encompasses a wide spectrum of healthcare systems, from highly specialized tertiary centers to rapidly expanding ambulatory care networks. Demand drivers in this region include large patient volumes for gastrointestinal and bronchial conditions, cost-sensitive procurement practices, and increasing investment in domestic manufacturing and R&D capabilities. Across all regions, tailored engagement that respects local reimbursement realities, clinical practice patterns, and supply-chain considerations will be necessary to translate technological promise into sustained clinical use.

Strategic company-level insights on product differentiation, clinical evidence pursuits, partnerships, and operational moves that determine competitive positioning

Competitive dynamics in the robotic endoscopy space reflect a balance between established medical device incumbents expanding into robotics and agile newcomers focused on disruptive platform features. Key company strategies include pursuing clinical evidence generation through investigator-initiated and sponsored studies, developing integrated service and training bundles to reduce adoption friction, and forging partnerships with hospitals and academic centers to accelerate real-world validation.

Product differentiation is being driven by unique value propositions such as modular instrument ecosystems, software-driven visualization and decision-support, and lifecycle service packages that include remote monitoring and predictive maintenance. Firms that can demonstrate interoperability with hospital ecosystems, robust regulatory pathways for software updates, and clear clinician training curricula gain an advantage in procurement discussions.

Strategic corporate activity has included selective vertical integration of critical subsystems, alliances with imaging and analytics companies, and targeted investments in manufacturing capacity to secure supply continuity. These moves reflect a pragmatic recognition that success in this domain requires not only compelling clinical performance but also dependable post-market support and the ability to scale commercially in diverse healthcare environments.

Actionable strategic recommendations for developers, providers, and commercial teams to accelerate adoption, mitigate supply risk, and secure durable clinical value

Industry leaders should prioritize an integrated approach that aligns device innovation with pragmatic adoption strategies. First, invest in robust clinical evidence programs that address real-world endpoints valued by payers and providers, and ensure that training pathways are embedded into commercial rollouts to reduce adoption friction. Second, strengthen supply-chain resilience through regional sourcing, dual-sourcing arrangements for critical components, and partnerships with contract manufacturers to minimize exposure to trade disruptions and tariff-related cost pressures.

Third, design commercial models that reflect institutional purchasing preferences by offering flexible financing, outcome-linked services, and scalable support packages tailored to ambulatory centers, clinics, and hospitals. Fourth, emphasize interoperability and software architecture that supports continuous improvement while satisfying evolving regulatory expectations for software as a medical device. Finally, pursue partnerships with clinical centers of excellence and research institutes to accelerate iterative product refinement and build compelling case studies that support broader reimbursement and procurement discussions.

By executing against these priorities, leaders can reduce time-to-adoption, mitigate operational risk, and position their platforms for durable clinical and commercial impact across diverse healthcare settings.

Clear research methodology detailing primary stakeholder engagement, observational analysis, and secondary technical and regulatory review used to produce actionable insights

The research synthesis behind this executive summary is grounded in a multi-method approach that combines primary stakeholder engagement with secondary technical and regulatory review. Primary inputs included structured interviews with clinical leaders, procurement executives, and device engineers to capture real-world adoption barriers, training requirements, and component sourcing practices. These conversations were complemented by targeted site visits and proctoring session observations to understand workflow implications and user experience nuances.

Secondary sources were consulted to contextualize technological trends, regulatory guidance, and public policy developments affecting cross-border trade and device classification. The analytical framework prioritized triangulation of qualitative insights with documented regulatory decisions and published clinical literature to ensure robustness. Where applicable, scenario assessments were used to evaluate the implications of supply-chain disruptions, policy shifts, and technology maturation for commercial planning.

Throughout the process, attention was given to transparency of assumptions, clear documentation of interview protocols, and rigorous review of clinical claims against publicly available evidence. The methodology supports practical recommendations while acknowledging areas where further primary research or long-term outcomes data would strengthen decision confidence.

Concluding synthesis emphasizing clinical promise, operational preconditions for adoption, and the strategic attributes that will determine long-term success

Robotic endoscopy occupies a pivotal position in the broader trajectory of minimally invasive care, offering tangible potential to improve diagnostic accuracy and enable therapeutic interventions with lower patient burden. The convergence of improved actuation, advanced imaging, and intelligent software is unlocking applications across bronchial, gastrointestinal, otolaryngological, and urological care pathways, while diverse platform technologies are responding to varied clinical and operational needs.

Nevertheless, success will hinge on more than technical performance. Sustained adoption requires thoughtfully designed training, procurement models that align incentives for providers and vendors, and resilient supply chains that can withstand geopolitical and tariff-related pressures. Regional differences in regulatory expectations and reimbursement mechanisms will continue to shape which innovations scale rapidly and which require extended evidence-generation periods.

In sum, the next phase of development will favor organizations that combine clinical rigor with operational excellence, strategic partnerships, and adaptive commercialization strategies. Stakeholders who integrate those capabilities can convert technological promise into measurable clinical and organizational value.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Definition
  • 1.3. Market Segmentation & Coverage
  • 1.4. Years Considered for the Study
  • 1.5. Currency Considered for the Study
  • 1.6. Language Considered for the Study
  • 1.7. Key Stakeholders

2. Research Methodology

  • 2.1. Introduction
  • 2.2. Research Design
    • 2.2.1. Primary Research
    • 2.2.2. Secondary Research
  • 2.3. Research Framework
    • 2.3.1. Qualitative Analysis
    • 2.3.2. Quantitative Analysis
  • 2.4. Market Size Estimation
    • 2.4.1. Top-Down Approach
    • 2.4.2. Bottom-Up Approach
  • 2.5. Data Triangulation
  • 2.6. Research Outcomes
  • 2.7. Research Assumptions
  • 2.8. Research Limitations

3. Executive Summary

  • 3.1. Introduction
  • 3.2. CXO Perspective
  • 3.3. Market Size & Growth Trends
  • 3.4. Market Share Analysis, 2025
  • 3.5. FPNV Positioning Matrix, 2025
  • 3.6. New Revenue Opportunities
  • 3.7. Next-Generation Business Models
  • 3.8. Industry Roadmap

4. Market Overview

  • 4.1. Introduction
  • 4.2. Industry Ecosystem & Value Chain Analysis
    • 4.2.1. Supply-Side Analysis
    • 4.2.2. Demand-Side Analysis
    • 4.2.3. Stakeholder Analysis
  • 4.3. Porter's Five Forces Analysis
  • 4.4. PESTLE Analysis
  • 4.5. Market Outlook
    • 4.5.1. Near-Term Market Outlook (0-2 Years)
    • 4.5.2. Medium-Term Market Outlook (3-5 Years)
    • 4.5.3. Long-Term Market Outlook (5-10 Years)
  • 4.6. Go-to-Market Strategy

5. Market Insights

  • 5.1. Consumer Insights & End-User Perspective
  • 5.2. Consumer Experience Benchmarking
  • 5.3. Opportunity Mapping
  • 5.4. Distribution Channel Analysis
  • 5.5. Pricing Trend Analysis
  • 5.6. Regulatory Compliance & Standards Framework
  • 5.7. ESG & Sustainability Analysis
  • 5.8. Disruption & Risk Scenarios
  • 5.9. Return on Investment & Cost-Benefit Analysis

6. Cumulative Impact of United States Tariffs 2025

7. Cumulative Impact of Artificial Intelligence 2025

8. Robotic Endoscopy Devices Market, by Device Type

  • 8.1. Diagnostic
    • 8.1.1. Biopsy
    • 8.1.2. Imaging
  • 8.2. Therapeutic
    • 8.2.1. Ablation
    • 8.2.2. Hemostasis
    • 8.2.3. Resection

9. Robotic Endoscopy Devices Market, by Technology

  • 9.1. Capsule Endoscope
  • 9.2. Flexible Robotic Endoscope
  • 9.3. Rigid Robotic Endoscope

10. Robotic Endoscopy Devices Market, by Application

  • 10.1. Bronchial
  • 10.2. Gastrointestinal
    • 10.2.1. Lower Gastrointestinal
    • 10.2.2. Upper Gastrointestinal
  • 10.3. Otolaryngological
  • 10.4. Urological

11. Robotic Endoscopy Devices Market, by End User

  • 11.1. Ambulatory Surgical Centers
  • 11.2. Clinics
  • 11.3. Hospitals
  • 11.4. Research Institutes

12. Robotic Endoscopy Devices Market, by Region

  • 12.1. Americas
    • 12.1.1. North America
    • 12.1.2. Latin America
  • 12.2. Europe, Middle East & Africa
    • 12.2.1. Europe
    • 12.2.2. Middle East
    • 12.2.3. Africa
  • 12.3. Asia-Pacific

13. Robotic Endoscopy Devices Market, by Group

  • 13.1. ASEAN
  • 13.2. GCC
  • 13.3. European Union
  • 13.4. BRICS
  • 13.5. G7
  • 13.6. NATO

14. Robotic Endoscopy Devices Market, by Country

  • 14.1. United States
  • 14.2. Canada
  • 14.3. Mexico
  • 14.4. Brazil
  • 14.5. United Kingdom
  • 14.6. Germany
  • 14.7. France
  • 14.8. Russia
  • 14.9. Italy
  • 14.10. Spain
  • 14.11. China
  • 14.12. India
  • 14.13. Japan
  • 14.14. Australia
  • 14.15. South Korea

15. United States Robotic Endoscopy Devices Market

16. China Robotic Endoscopy Devices Market

17. Competitive Landscape

  • 17.1. Market Concentration Analysis, 2025
    • 17.1.1. Concentration Ratio (CR)
    • 17.1.2. Herfindahl Hirschman Index (HHI)
  • 17.2. Recent Developments & Impact Analysis, 2025
  • 17.3. Product Portfolio Analysis, 2025
  • 17.4. Benchmarking Analysis, 2025
  • 17.5. Ambu A/S
  • 17.6. Asensus Surgical, Inc.
  • 17.7. avateramedical GmbH
  • 17.8. Boston Scientific Corporation
  • 17.9. Brainlab AG
  • 17.10. CMR Surgical Ltd.
  • 17.11. Cook Group Incorporated
  • 17.12. EndoMaster Pte Ltd
  • 17.13. Endotics
  • 17.14. Globus Medical, Inc.
  • 17.15. Intuitive Surgical, Inc.
  • 17.16. KARL STORZ SE & Co. KG
  • 17.17. Medtronic PLC
  • 17.18. MicroPort Scientific Corporation
  • 17.19. Olympus Corporation
  • 17.20. Otsuka Holdings Co., Ltd.
  • 17.21. Renishaw PLC
  • 17.22. Ronovo Surgical
  • 17.23. Stryker Corporation
  • 17.24. Virtuoso Surgical, Inc.

LIST OF FIGURES

  • FIGURE 1. GLOBAL ROBOTIC ENDOSCOPY DEVICES MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 2. GLOBAL ROBOTIC ENDOSCOPY DEVICES MARKET SHARE, BY KEY PLAYER, 2025
  • FIGURE 3. GLOBAL ROBOTIC ENDOSCOPY DEVICES MARKET, FPNV POSITIONING MATRIX, 2025
  • FIGURE 4. GLOBAL ROBOTIC ENDOSCOPY DEVICES MARKET SIZE, BY DEVICE TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 5. GLOBAL ROBOTIC ENDOSCOPY DEVICES MARKET SIZE, BY TECHNOLOGY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 6. GLOBAL ROBOTIC ENDOSCOPY DEVICES MARKET SIZE, BY APPLICATION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 7. GLOBAL ROBOTIC ENDOSCOPY DEVICES MARKET SIZE, BY END USER, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 8. GLOBAL ROBOTIC ENDOSCOPY DEVICES MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 9. GLOBAL ROBOTIC ENDOSCOPY DEVICES MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL ROBOTIC ENDOSCOPY DEVICES MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 11. UNITED STATES ROBOTIC ENDOSCOPY DEVICES MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 12. CHINA ROBOTIC ENDOSCOPY DEVICES MARKET SIZE, 2018-2032 (USD MILLION)

LIST OF TABLES

  • TABLE 1. GLOBAL ROBOTIC ENDOSCOPY DEVICES MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 2. GLOBAL ROBOTIC ENDOSCOPY DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 3. GLOBAL ROBOTIC ENDOSCOPY DEVICES MARKET SIZE, BY DIAGNOSTIC, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 4. GLOBAL ROBOTIC ENDOSCOPY DEVICES MARKET SIZE, BY DIAGNOSTIC, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 5. GLOBAL ROBOTIC ENDOSCOPY DEVICES MARKET SIZE, BY DIAGNOSTIC, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 6. GLOBAL ROBOTIC ENDOSCOPY DEVICES MARKET SIZE, BY DIAGNOSTIC, 2018-2032 (USD MILLION)
  • TABLE 7. GLOBAL ROBOTIC ENDOSCOPY DEVICES MARKET SIZE, BY BIOPSY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 8. GLOBAL ROBOTIC ENDOSCOPY DEVICES MARKET SIZE, BY BIOPSY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 9. GLOBAL ROBOTIC ENDOSCOPY DEVICES MARKET SIZE, BY BIOPSY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 10. GLOBAL ROBOTIC ENDOSCOPY DEVICES MARKET SIZE, BY IMAGING, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 11. GLOBAL ROBOTIC ENDOSCOPY DEVICES MARKET SIZE, BY IMAGING, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 12. GLOBAL ROBOTIC ENDOSCOPY DEVICES MARKET SIZE, BY IMAGING, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 13. GLOBAL ROBOTIC ENDOSCOPY DEVICES MARKET SIZE, BY THERAPEUTIC, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 14. GLOBAL ROBOTIC ENDOSCOPY DEVICES MARKET SIZE, BY THERAPEUTIC, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 15. GLOBAL ROBOTIC ENDOSCOPY DEVICES MARKET SIZE, BY THERAPEUTIC, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 16. GLOBAL ROBOTIC ENDOSCOPY DEVICES MARKET SIZE, BY THERAPEUTIC, 2018-2032 (USD MILLION)
  • TABLE 17. GLOBAL ROBOTIC ENDOSCOPY DEVICES MARKET SIZE, BY ABLATION, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 18. GLOBAL ROBOTIC ENDOSCOPY DEVICES MARKET SIZE, BY ABLATION, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 19. GLOBAL ROBOTIC ENDOSCOPY DEVICES MARKET SIZE, BY ABLATION, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 20. GLOBAL ROBOTIC ENDOSCOPY DEVICES MARKET SIZE, BY HEMOSTASIS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 21. GLOBAL ROBOTIC ENDOSCOPY DEVICES MARKET SIZE, BY HEMOSTASIS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 22. GLOBAL ROBOTIC ENDOSCOPY DEVICES MARKET SIZE, BY HEMOSTASIS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 23. GLOBAL ROBOTIC ENDOSCOPY DEVICES MARKET SIZE, BY RESECTION, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 24. GLOBAL ROBOTIC ENDOSCOPY DEVICES MARKET SIZE, BY RESECTION, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 25. GLOBAL ROBOTIC ENDOSCOPY DEVICES MARKET SIZE, BY RESECTION, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 26. GLOBAL ROBOTIC ENDOSCOPY DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 27. GLOBAL ROBOTIC ENDOSCOPY DEVICES MARKET SIZE, BY CAPSULE ENDOSCOPE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 28. GLOBAL ROBOTIC ENDOSCOPY DEVICES MARKET SIZE, BY CAPSULE ENDOSCOPE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 29. GLOBAL ROBOTIC ENDOSCOPY DEVICES MARKET SIZE, BY CAPSULE ENDOSCOPE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 30. GLOBAL ROBOTIC ENDOSCOPY DEVICES MARKET SIZE, BY FLEXIBLE ROBOTIC ENDOSCOPE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 31. GLOBAL ROBOTIC ENDOSCOPY DEVICES MARKET SIZE, BY FLEXIBLE ROBOTIC ENDOSCOPE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 32. GLOBAL ROBOTIC ENDOSCOPY DEVICES MARKET SIZE, BY FLEXIBLE ROBOTIC ENDOSCOPE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 33. GLOBAL ROBOTIC ENDOSCOPY DEVICES MARKET SIZE, BY RIGID ROBOTIC ENDOSCOPE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 34. GLOBAL ROBOTIC ENDOSCOPY DEVICES MARKET SIZE, BY RIGID ROBOTIC ENDOSCOPE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 35. GLOBAL ROBOTIC ENDOSCOPY DEVICES MARKET SIZE, BY RIGID ROBOTIC ENDOSCOPE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 36. GLOBAL ROBOTIC ENDOSCOPY DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 37. GLOBAL ROBOTIC ENDOSCOPY DEVICES MARKET SIZE, BY BRONCHIAL, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 38. GLOBAL ROBOTIC ENDOSCOPY DEVICES MARKET SIZE, BY BRONCHIAL, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 39. GLOBAL ROBOTIC ENDOSCOPY DEVICES MARKET SIZE, BY BRONCHIAL, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 40. GLOBAL ROBOTIC ENDOSCOPY DEVICES MARKET SIZE, BY GASTROINTESTINAL, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 41. GLOBAL ROBOTIC ENDOSCOPY DEVICES MARKET SIZE, BY GASTROINTESTINAL, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 42. GLOBAL ROBOTIC ENDOSCOPY DEVICES MARKET SIZE, BY GASTROINTESTINAL, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 43. GLOBAL ROBOTIC ENDOSCOPY DEVICES MARKET SIZE, BY GASTROINTESTINAL, 2018-2032 (USD MILLION)
  • TABLE 44. GLOBAL ROBOTIC ENDOSCOPY DEVICES MARKET SIZE, BY LOWER GASTROINTESTINAL, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 45. GLOBAL ROBOTIC ENDOSCOPY DEVICES MARKET SIZE, BY LOWER GASTROINTESTINAL, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 46. GLOBAL ROBOTIC ENDOSCOPY DEVICES MARKET SIZE, BY LOWER GASTROINTESTINAL, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 47. GLOBAL ROBOTIC ENDOSCOPY DEVICES MARKET SIZE, BY UPPER GASTROINTESTINAL, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 48. GLOBAL ROBOTIC ENDOSCOPY DEVICES MARKET SIZE, BY UPPER GASTROINTESTINAL, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 49. GLOBAL ROBOTIC ENDOSCOPY DEVICES MARKET SIZE, BY UPPER GASTROINTESTINAL, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 50. GLOBAL ROBOTIC ENDOSCOPY DEVICES MARKET SIZE, BY OTOLARYNGOLOGICAL, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 51. GLOBAL ROBOTIC ENDOSCOPY DEVICES MARKET SIZE, BY OTOLARYNGOLOGICAL, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 52. GLOBAL ROBOTIC ENDOSCOPY DEVICES MARKET SIZE, BY OTOLARYNGOLOGICAL, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 53. GLOBAL ROBOTIC ENDOSCOPY DEVICES MARKET SIZE, BY UROLOGICAL, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 54. GLOBAL ROBOTIC ENDOSCOPY DEVICES MARKET SIZE, BY UROLOGICAL, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 55. GLOBAL ROBOTIC ENDOSCOPY DEVICES MARKET SIZE, BY UROLOGICAL, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 56. GLOBAL ROBOTIC ENDOSCOPY DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 57. GLOBAL ROBOTIC ENDOSCOPY DEVICES MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 58. GLOBAL ROBOTIC ENDOSCOPY DEVICES MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 59. GLOBAL ROBOTIC ENDOSCOPY DEVICES MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 60. GLOBAL ROBOTIC ENDOSCOPY DEVICES MARKET SIZE, BY CLINICS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 61. GLOBAL ROBOTIC ENDOSCOPY DEVICES MARKET SIZE, BY CLINICS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 62. GLOBAL ROBOTIC ENDOSCOPY DEVICES MARKET SIZE, BY CLINICS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 63. GLOBAL ROBOTIC ENDOSCOPY DEVICES MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 64. GLOBAL ROBOTIC ENDOSCOPY DEVICES MARKET SIZE, BY HOSPITALS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 65. GLOBAL ROBOTIC ENDOSCOPY DEVICES MARKET SIZE, BY HOSPITALS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 66. GLOBAL ROBOTIC ENDOSCOPY DEVICES MARKET SIZE, BY RESEARCH INSTITUTES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 67. GLOBAL ROBOTIC ENDOSCOPY DEVICES MARKET SIZE, BY RESEARCH INSTITUTES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 68. GLOBAL ROBOTIC ENDOSCOPY DEVICES MARKET SIZE, BY RESEARCH INSTITUTES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 69. GLOBAL ROBOTIC ENDOSCOPY DEVICES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 70. AMERICAS ROBOTIC ENDOSCOPY DEVICES MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 71. AMERICAS ROBOTIC ENDOSCOPY DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 72. AMERICAS ROBOTIC ENDOSCOPY DEVICES MARKET SIZE, BY DIAGNOSTIC, 2018-2032 (USD MILLION)
  • TABLE 73. AMERICAS ROBOTIC ENDOSCOPY DEVICES MARKET SIZE, BY THERAPEUTIC, 2018-2032 (USD MILLION)
  • TABLE 74. AMERICAS ROBOTIC ENDOSCOPY DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 75. AMERICAS ROBOTIC ENDOSCOPY DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 76. AMERICAS ROBOTIC ENDOSCOPY DEVICES MARKET SIZE, BY GASTROINTESTINAL, 2018-2032 (USD MILLION)
  • TABLE 77. AMERICAS ROBOTIC ENDOSCOPY DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 78. NORTH AMERICA ROBOTIC ENDOSCOPY DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 79. NORTH AMERICA ROBOTIC ENDOSCOPY DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 80. NORTH AMERICA ROBOTIC ENDOSCOPY DEVICES MARKET SIZE, BY DIAGNOSTIC, 2018-2032 (USD MILLION)
  • TABLE 81. NORTH AMERICA ROBOTIC ENDOSCOPY DEVICES MARKET SIZE, BY THERAPEUTIC, 2018-2032 (USD MILLION)
  • TABLE 82. NORTH AMERICA ROBOTIC ENDOSCOPY DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 83. NORTH AMERICA ROBOTIC ENDOSCOPY DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 84. NORTH AMERICA ROBOTIC ENDOSCOPY DEVICES MARKET SIZE, BY GASTROINTESTINAL, 2018-2032 (USD MILLION)
  • TABLE 85. NORTH AMERICA ROBOTIC ENDOSCOPY DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 86. LATIN AMERICA ROBOTIC ENDOSCOPY DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 87. LATIN AMERICA ROBOTIC ENDOSCOPY DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 88. LATIN AMERICA ROBOTIC ENDOSCOPY DEVICES MARKET SIZE, BY DIAGNOSTIC, 2018-2032 (USD MILLION)
  • TABLE 89. LATIN AMERICA ROBOTIC ENDOSCOPY DEVICES MARKET SIZE, BY THERAPEUTIC, 2018-2032 (USD MILLION)
  • TABLE 90. LATIN AMERICA ROBOTIC ENDOSCOPY DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 91. LATIN AMERICA ROBOTIC ENDOSCOPY DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 92. LATIN AMERICA ROBOTIC ENDOSCOPY DEVICES MARKET SIZE, BY GASTROINTESTINAL, 2018-2032 (USD MILLION)
  • TABLE 93. LATIN AMERICA ROBOTIC ENDOSCOPY DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 94. EUROPE, MIDDLE EAST & AFRICA ROBOTIC ENDOSCOPY DEVICES MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 95. EUROPE, MIDDLE EAST & AFRICA ROBOTIC ENDOSCOPY DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 96. EUROPE, MIDDLE EAST & AFRICA ROBOTIC ENDOSCOPY DEVICES MARKET SIZE, BY DIAGNOSTIC, 2018-2032 (USD MILLION)
  • TABLE 97. EUROPE, MIDDLE EAST & AFRICA ROBOTIC ENDOSCOPY DEVICES MARKET SIZE, BY THERAPEUTIC, 2018-2032 (USD MILLION)
  • TABLE 98. EUROPE, MIDDLE EAST & AFRICA ROBOTIC ENDOSCOPY DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 99. EUROPE, MIDDLE EAST & AFRICA ROBOTIC ENDOSCOPY DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 100. EUROPE, MIDDLE EAST & AFRICA ROBOTIC ENDOSCOPY DEVICES MARKET SIZE, BY GASTROINTESTINAL, 2018-2032 (USD MILLION)
  • TABLE 101. EUROPE, MIDDLE EAST & AFRICA ROBOTIC ENDOSCOPY DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 102. EUROPE ROBOTIC ENDOSCOPY DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 103. EUROPE ROBOTIC ENDOSCOPY DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 104. EUROPE ROBOTIC ENDOSCOPY DEVICES MARKET SIZE, BY DIAGNOSTIC, 2018-2032 (USD MILLION)
  • TABLE 105. EUROPE ROBOTIC ENDOSCOPY DEVICES MARKET SIZE, BY THERAPEUTIC, 2018-2032 (USD MILLION)
  • TABLE 106. EUROPE ROBOTIC ENDOSCOPY DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 107. EUROPE ROBOTIC ENDOSCOPY DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 108. EUROPE ROBOTIC ENDOSCOPY DEVICES MARKET SIZE, BY GASTROINTESTINAL, 2018-2032 (USD MILLION)
  • TABLE 109. EUROPE ROBOTIC ENDOSCOPY DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 110. MIDDLE EAST ROBOTIC ENDOSCOPY DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 111. MIDDLE EAST ROBOTIC ENDOSCOPY DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 112. MIDDLE EAST ROBOTIC ENDOSCOPY DEVICES MARKET SIZE, BY DIAGNOSTIC, 2018-2032 (USD MILLION)
  • TABLE 113. MIDDLE EAST ROBOTIC ENDOSCOPY DEVICES MARKET SIZE, BY THERAPEUTIC, 2018-2032 (USD MILLION)
  • TABLE 114. MIDDLE EAST ROBOTIC ENDOSCOPY DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 115. MIDDLE EAST ROBOTIC ENDOSCOPY DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 116. MIDDLE EAST ROBOTIC ENDOSCOPY DEVICES MARKET SIZE, BY GASTROINTESTINAL, 2018-2032 (USD MILLION)
  • TABLE 117. MIDDLE EAST ROBOTIC ENDOSCOPY DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 118. AFRICA ROBOTIC ENDOSCOPY DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 119. AFRICA ROBOTIC ENDOSCOPY DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 120. AFRICA ROBOTIC ENDOSCOPY DEVICES MARKET SIZE, BY DIAGNOSTIC, 2018-2032 (USD MILLION)
  • TABLE 121. AFRICA ROBOTIC ENDOSCOPY DEVICES MARKET SIZE, BY THERAPEUTIC, 2018-2032 (USD MILLION)
  • TABLE 122. AFRICA ROBOTIC ENDOSCOPY DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 123. AFRICA ROBOTIC ENDOSCOPY DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 124. AFRICA ROBOTIC ENDOSCOPY DEVICES MARKET SIZE, BY GASTROINTESTINAL, 2018-2032 (USD MILLION)
  • TABLE 125. AFRICA ROBOTIC ENDOSCOPY DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 126. ASIA-PACIFIC ROBOTIC ENDOSCOPY DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 127. ASIA-PACIFIC ROBOTIC ENDOSCOPY DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 128. ASIA-PACIFIC ROBOTIC ENDOSCOPY DEVICES MARKET SIZE, BY DIAGNOSTIC, 2018-2032 (USD MILLION)
  • TABLE 129. ASIA-PACIFIC ROBOTIC ENDOSCOPY DEVICES MARKET SIZE, BY THERAPEUTIC, 2018-2032 (USD MILLION)
  • TABLE 130. ASIA-PACIFIC ROBOTIC ENDOSCOPY DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 131. ASIA-PACIFIC ROBOTIC ENDOSCOPY DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 132. ASIA-PACIFIC ROBOTIC ENDOSCOPY DEVICES MARKET SIZE, BY GASTROINTESTINAL, 2018-2032 (USD MILLION)
  • TABLE 133. ASIA-PACIFIC ROBOTIC ENDOSCOPY DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 134. GLOBAL ROBOTIC ENDOSCOPY DEVICES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 135. ASEAN ROBOTIC ENDOSCOPY DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 136. ASEAN ROBOTIC ENDOSCOPY DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 137. ASEAN ROBOTIC ENDOSCOPY DEVICES MARKET SIZE, BY DIAGNOSTIC, 2018-2032 (USD MILLION)
  • TABLE 138. ASEAN ROBOTIC ENDOSCOPY DEVICES MARKET SIZE, BY THERAPEUTIC, 2018-2032 (USD MILLION)
  • TABLE 139. ASEAN ROBOTIC ENDOSCOPY DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 140. ASEAN ROBOTIC ENDOSCOPY DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 141. ASEAN ROBOTIC ENDOSCOPY DEVICES MARKET SIZE, BY GASTROINTESTINAL, 2018-2032 (USD MILLION)
  • TABLE 142. ASEAN ROBOTIC ENDOSCOPY DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 143. GCC ROBOTIC ENDOSCOPY DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 144. GCC ROBOTIC ENDOSCOPY DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 145. GCC ROBOTIC ENDOSCOPY DEVICES MARKET SIZE, BY DIAGNOSTIC, 2018-2032 (USD MILLION)
  • TABLE 146. GCC ROBOTIC ENDOSCOPY DEVICES MARKET SIZE, BY THERAPEUTIC, 2018-2032 (USD MILLION)
  • TABLE 147. GCC ROBOTIC ENDOSCOPY DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 148. GCC ROBOTIC ENDOSCOPY DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 149. GCC ROBOTIC ENDOSCOPY DEVICES MARKET SIZE, BY GASTROINTESTINAL, 2018-2032 (USD MILLION)
  • TABLE 150. GCC ROBOTIC ENDOSCOPY DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 151. EUROPEAN UNION ROBOTIC ENDOSCOPY DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 152. EUROPEAN UNION ROBOTIC ENDOSCOPY DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 153. EUROPEAN UNION ROBOTIC ENDOSCOPY DEVICES MARKET SIZE, BY DIAGNOSTIC, 2018-2032 (USD MILLION)
  • TABLE 154. EUROPEAN UNION ROBOTIC ENDOSCOPY DEVICES MARKET SIZE, BY THERAPEUTIC, 2018-2032 (USD MILLION)
  • TABLE 155. EUROPEAN UNION ROBOTIC ENDOSCOPY DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 156. EUROPEAN UNION ROBOTIC ENDOSCOPY DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 157. EUROPEAN UNION ROBOTIC ENDOSCOPY DEVICES MARKET SIZE, BY GASTROINTESTINAL, 2018-2032 (USD MILLION)
  • TABLE 158. EUROPEAN UNION ROBOTIC ENDOSCOPY DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 159. BRICS ROBOTIC ENDOSCOPY DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 160. BRICS ROBOTIC ENDOSCOPY DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 161. BRICS ROBOTIC ENDOSCOPY DEVICES MARKET SIZE, BY DIAGNOSTIC, 2018-2032 (USD MILLION)
  • TABLE 162. BRICS ROBOTIC ENDOSCOPY DEVICES MARKET SIZE, BY THERAPEUTIC, 2018-2032 (USD MILLION)
  • TABLE 163. BRICS ROBOTIC ENDOSCOPY DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 164. BRICS ROBOTIC ENDOSCOPY DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 165. BRICS ROBOTIC ENDOSCOPY DEVICES MARKET SIZE, BY GASTROINTESTINAL, 2018-2032 (USD MILLION)
  • TABLE 166. BRICS ROBOTIC ENDOSCOPY DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 167. G7 ROBOTIC ENDOSCOPY DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 168. G7 ROBOTIC ENDOSCOPY DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 169. G7 ROBOTIC ENDOSCOPY DEVICES MARKET SIZE, BY DIAGNOSTIC, 2018-2032 (USD MILLION)
  • TABLE 170. G7 ROBOTIC ENDOSCOPY DEVICES MARKET SIZE, BY THERAPEUTIC, 2018-2032 (USD MILLION)
  • TABLE 171. G7 ROBOTIC ENDOSCOPY DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 172. G7 ROBOTIC ENDOSCOPY DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 173. G7 ROBOTIC ENDOSCOPY DEVICES MARKET SIZE, BY GASTROINTESTINAL, 2018-2032 (USD MILLION)
  • TABLE 174. G7 ROBOTIC ENDOSCOPY DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 175. NATO ROBOTIC ENDOSCOPY DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 176. NATO ROBOTIC ENDOSCOPY DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 177. NATO ROBOTIC ENDOSCOPY DEVICES MARKET SIZE, BY DIAGNOSTIC, 2018-2032 (USD MILLION)
  • TABLE 178. NATO ROBOTIC ENDOSCOPY DEVICES MARKET SIZE, BY THERAPEUTIC, 2018-2032 (USD MILLION)
  • TABLE 179. NATO ROBOTIC ENDOSCOPY DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 180. NATO ROBOTIC ENDOSCOPY DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 181. NATO ROBOTIC ENDOSCOPY DEVICES MARKET SIZE, BY GASTROINTESTINAL, 2018-2032 (USD MILLION)
  • TABLE 182. NATO ROBOTIC ENDOSCOPY DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 183. GLOBAL ROBOTIC ENDOSCOPY DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 184. UNITED STATES ROBOTIC ENDOSCOPY DEVICES MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 185. UNITED STATES ROBOTIC ENDOSCOPY DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 186. UNITED STATES ROBOTIC ENDOSCOPY DEVICES MARKET SIZE, BY DIAGNOSTIC, 2018-2032 (USD MILLION)
  • TABLE 187. UNITED STATES ROBOTIC ENDOSCOPY DEVICES MARKET SIZE, BY THERAPEUTIC, 2018-2032 (USD MILLION)
  • TABLE 188. UNITED STATES ROBOTIC ENDOSCOPY DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 189. UNITED STATES ROBOTIC ENDOSCOPY DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 190. UNITED STATES ROBOTIC ENDOSCOPY DEVICES MARKET SIZE, BY GASTROINTESTINAL, 2018-2032 (USD MILLION)
  • TABLE 191. UNITED STATES ROBOTIC ENDOSCOPY DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 192. CHINA ROBOTIC ENDOSCOPY DEVICES MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 193. CHINA ROBOTIC ENDOSCOPY DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 194. CHINA ROBOTIC ENDOSCOPY DEVICES MARKET SIZE, BY DIAGNOSTIC, 2018-2032 (USD MILLION)
  • TABLE 195. CHINA ROBOTIC ENDOSCOPY DEVICES MARKET SIZE, BY THERAPEUTIC, 2018-2032 (USD MILLION)
  • TABLE 196. CHINA ROBOTIC ENDOSCOPY DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 197. CHINA ROBOTIC ENDOSCOPY DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 198. CHINA ROBOTIC ENDOSCOPY DEVICES MARKET SIZE, BY GASTROINTESTINAL, 2018-2032 (USD MILLION)
  • TABLE 199. CHINA ROBOTIC ENDOSCOPY DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)